PA HR430

Designates May 3-9, 2026 as "Tardive Dyskinesia Awareness Week" in Pennsylvania

Tardive dyskinesia (TD) causes uncontrollable, abnormal movements of the face, torso, and limbs as a side effect of prolonged antipsychotic medication use

Approximately 60% of the estimated 800,000 U.S. adults living with TD remain undiagnosed

Higher-risk populations include individuals age 55+, Black individuals, women, and those with mood disorders, substance use disorders, or intellectual disabilities

Encourages TD screening education and awareness for health care providers, patients, and care partners in alignment with American Psychiatric Association guidelines